Cite
HARVARD Citation
Mackley, M. et al. (2021). Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta‐Analysis of Phase I Trials of Targeted Single‐Agent Anticancer Therapies. JCO precision oncology. p. . [Online].